{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T23:20:01Z","timestamp":1791069601617,"version":"4.1.0"},"reference-count":41,"publisher":"Wiley","license":[{"start":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:00:00Z","timestamp":1631577600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Case Reports in Medicine"],"published-print":{"date-parts":[[2021,9,14]]},"abstract":"<jats:p>Background. Acquired hemophilia A (AHA) is a potentially life-threatening autoimmune hemostatic disorder where autoantibodies that disrupt the functions of factor VIII (FVIII) are present in the circulation. The early diagnosis of AHA is difficult since the symptoms of AHA differ from those of congenital hemophilia A. Furthermore, the management of AHA is also more complex due to the presence of autoantibodies against FVIII (FVIII inhibitors). Here, we present three case reports and conduct a literature review of AHA with the aim to increase awareness and knowledge regarding the diagnosis and treatment of AHA. Case Presentations. We present three patients diagnosed with AHA in these case reports. The first patient was a young female, while the second and third patients were middle-aged and elderly males, respectively. All patients presented with a chief complaint of bruises without hemarthrosis and a history of bleeding. Laboratory examinations of the patients revealed isolated prolonged aPTT, normal PT, and the presence of autoantibodies against factor VIII, which are characteristics of AHA. Patients were then treated with corticosteroids to reduce the titer level of autoantibodies and received factor VIII transfusion to stop bleeding. Conclusion. AHA can be suspected in patients presenting with symptoms of bruises without hemarthrosis and without the history of bleeding. Isolated aPTT elevation with normal PT should raise high suspicion of AHA. The presence of FVIII inhibitors can help to confirm the diagnosis of AHA. Treatment consists of factor VIII transfusion and corticosteroid therapy. Bypassing agents are recommended as an alternative to FVIII transfusion.<\/jats:p>","DOI":"10.1155\/2021\/5554664","type":"journal-article","created":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T14:05:28Z","timestamp":1631714728000},"page":"1-9","source":"Crossref","is-referenced-by-count":4,"title":["Diagnosis and Management of Acquired Hemophilia A: Case Reports and a Literature Review"],"prefix":"10.1155","volume":"2021","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6872-8802","authenticated-orcid":true,"given":"Ikhwan","family":"Rinaldi","sequence":"first","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Findy","family":"Prasetyawaty","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology, Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siti","family":"Fazlines","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Cipto Mangunkusumo National General Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2667-1999","authenticated-orcid":true,"given":"Kevin","family":"Winston","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8881-6172","authenticated-orcid":true,"given":"Yusuf Aji","family":"Samudera Nurrobi","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7421-6048","authenticated-orcid":true,"given":"Jessica","family":"Leoni","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilham Hidayat","family":"Restu Tulus Maha","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satrio","family":"Wicaksono","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdillah Yasir","family":"Wicaksono","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Averina Octaxena","family":"Aslani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizkania","family":"Ikhsani","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2006.1.432"},{"key":"2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2018.10.011"},{"key":"3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04654.x"},{"key":"4","first-page":"143","article-title":"Acquired hemophilia A: emerging treatment options","volume":"6","author":"M. Janbain","year":"2015","journal-title":"Journal of Blood Medicine"},{"key":"5","volume-title":"Acquired Hemophilia","author":"M. Z. Haider","year":"2020"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24777"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12463"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1097\/mbc.0b013e32832ca388"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-029850"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04731.x"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1245109"},{"key":"12","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1390004"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jfma.2013.01.006"},{"issue":"1","key":"14","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/ajh.20390","article-title":"Acquired hemophilia A: A concise review","volume":"80","author":"M. Franchini","year":"2005","journal-title":"American Society of Hematology"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.5603\/gp.2019.0063"},{"issue":"7","key":"16","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3324\/haematol.2019.230771","article-title":"International recommendations on the diagnosis and treatment of acquired hemophilia A","volume":"105","author":"A. Tiede","year":"2020","journal-title":"Haematologica"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.11.005"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1336832"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.12925"},{"key":"20","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-62703-339-8_24"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1186\/1756-0500-3-161"},{"key":"22","first-page":"64","article-title":"New protocol for immune tolerance induction in acquired hemophilia","volume":"85","author":"L. Nemes","year":"2000","journal-title":"Haematologica"},{"key":"23","doi-asserted-by":"publisher","DOI":"10.1111\/hae.14046"},{"key":"24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/hae.12627","article-title":"Efficacy and safety of OBI-1, an antihaemophilic factor VIII (recombinant), porcine sequence, in subjects with acquired haemophilia A","volume":"21","author":"R. Kruse-Jarres","year":"2015","journal-title":"Haemophilia"},{"issue":"1","key":"25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/jth.14618","article-title":"Cross-reacting inhibitors against recombinant porcine factor VIII in acquired hemophilia A: Data from the GTH-AH 01\/2010 Study","volume":"18","author":"H. T\u00fcrkantoz","year":"2020","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1111\/hae.13040"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-02-408930"},{"issue":"3","key":"28","first-page":"498","article-title":"Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management","volume":"13","author":"M. Franchini","year":"2015","journal-title":"Blood Transfus"},{"key":"29","doi-asserted-by":"publisher","DOI":"10.5812\/aapm.11906"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2012.04793.x"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12574"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1160\/th17-05-0365"},{"key":"33","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/hae.12318","article-title":"Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors","volume":"20","author":"H. T. T. Tran","year":"2014","journal-title":"Haemophilia"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2516.2012.02748.x"},{"issue":"12","key":"35","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1111\/j.1538-7836.2007.02755.x","article-title":"Tranexamic acid combined with recombinant factor VIII increases clot resistance to accelerated fibrinolysis in severe hemophilia A","volume":"5","author":"A.-M. Hvas","year":"2007","journal-title":"Journal of Thrombosis and Haemostasis"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1161\/01.atv.20.12.2689"},{"issue":"4","key":"37","first-page":"377","article-title":"The use of desmopressin in acquired haemophilia A: a systematic review","volume":"9","author":"M. Franchini","year":"2011","journal-title":"Blood Transfusion"},{"key":"38","article-title":"Immunosuppression for acquired hemophilia a: results from the european acquired haemophilia registry (EACH2)","author":"P. Collins","year":"2012","journal-title":"Blood"},{"key":"39","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1182\/blood-2014-07-587089","article-title":"Prognostic factors for remission of and survival in acquired hemophilia A (AHA): Results from the GTH-AH 01\/2010 study","volume":"125","author":"A. Tiede","year":"2015","journal-title":"Blood"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2003.04162.x"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.5442"}],"container-title":["Case Reports in Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/crim\/2021\/5554664.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/crim\/2021\/5554664.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/crim\/2021\/5554664.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,15]],"date-time":"2021-09-15T14:05:44Z","timestamp":1631714744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/crim\/2021\/5554664\/"}},"subtitle":[],"editor":[{"given":"Aristomenis K.","family":"Exadaktylos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,14]]},"references-count":41,"alternative-id":["5554664","5554664"],"URL":"https:\/\/doi.org\/10.1155\/2021\/5554664","relation":{},"ISSN":["1687-9635","1687-9627"],"issn-type":[{"value":"1687-9635","type":"electronic"},{"value":"1687-9627","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,14]]}}}